FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways
Presenter:
Advertisement
Sign In
New at TCTMD? Register today!
Forgot Your Password?
Enter the email you used to register to reset your password.
Search TCTMD
cme